Talamini M A, Chapman S, Horgan S, Melvin W S
Department of Surgery, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Surg Endosc. 2003 Oct;17(10):1521-4. doi: 10.1007/s00464-002-8853-3. Epub 2003 Aug 15.
The Academic Robotics Group prospectively studied 211 robotically assisted operations to assess the safety and utility of robotically assisted surgery.
All operations took place at one of four member institutions between June 2000 and June 2001 using the recently FDA-approved daVinci robotic system. A variety of procedures were undertaken, including antireflux surgery (69), cholecystectomy (36), Heller myotomy (26), bowel resection (17), donor nephrectomy (15), left internal mammery artery mobilization (14), gastric bypass (seven), splenectomy (seven), adrenalectomy (six), exploratory laparoscopy (three), pyloroplasty (four), gastrojejunostomy (two), distal pancreatectomy (one), duodenal polypectomy (one), esophagectomy (one), gastric mass resection (one), and lysis of adhesions (one).
Average operating room time was 188 min (range 45 to 387, SD = 83), surgical time 143 min (range 35 to 462, SD = 63), and robot time 90 min (range 12 to 235, SD = 47). Median length of stay was 1 day (range 0 to 37). There were 8 (4%) technical complications during procedures, five minor (four hook cautery dislodgement, one slipped robotic trocar) and three major (system malfunctions, two of which required conversion to standard laparoscopy). In all cases, technical problems caused only delay, without apparent altered outcome. There were medical/surgical complications in nine patients (4%). Six (3%) were considered major, including one death unrelated to the robotic procedure.
The results of robotic-assisted surgery compare favorably with those of conventional laparoscopy with respect to mortality, complications, and length of stay. Robotic-assisted surgery is safe and effective and is a new reality for American surgery. The role of these devices in surgery will expand as the technology evolves.
学术机器人研究小组对211例机器人辅助手术进行了前瞻性研究,以评估机器人辅助手术的安全性和实用性。
2000年6月至2001年6月期间,所有手术均在四家成员机构之一使用最近获得美国食品药品监督管理局(FDA)批准的达芬奇机器人系统进行。进行了多种手术,包括抗反流手术(69例)、胆囊切除术(36例)、贲门肌切开术(26例)、肠切除术(17例)、供体肾切除术(15例)、左乳内动脉游离术(14例)、胃旁路手术(7例)、脾切除术(7例)、肾上腺切除术(6例)、探索性腹腔镜检查(3例)、幽门成形术(4例)、胃空肠吻合术(2例)、远端胰腺切除术(1例)、十二指肠息肉切除术(1例)、食管切除术(1例)、胃肿物切除术(1例)和粘连松解术(1例)。
平均手术时间为188分钟(范围45至387分钟,标准差=83),手术时长143分钟(范围35至462分钟,标准差=63),机器人操作时间90分钟(范围12至235分钟,标准差=47)。中位住院时间为1天(范围0至37天)。手术过程中有8例(4%)技术并发症,5例轻微并发症(4例钩状电灼器移位,1例机器人套管针滑脱)和3例严重并发症(系统故障,其中2例需要转为标准腹腔镜手术)。在所有病例中,技术问题仅导致了手术延迟,并未明显改变手术结果。9例患者(4%)出现了医疗/手术并发症。6例(3%)被认为是严重并发症,包括1例与机器人手术无关的死亡病例。
机器人辅助手术在死亡率、并发症和住院时间方面与传统腹腔镜手术相比具有优势。机器人辅助手术安全有效,是美国外科手术的新现实。随着技术的发展,这些设备在手术中的作用将不断扩大。